
Telmitos AM 40mg/5mg/12.5mg Tablet
Marketer
Atos Lifesciences Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telmitos AM 40mg/5mg/12.5mg Tablet
Amlodipine/Atenolol/Hydrochlorothiazide 40mg/5mg/12.5mg tablets are a triple-combination therapy for managing hypertension when monotherapy proves insufficient. This medication lowers elevated blood pressure, consequently reducing the risk of future cardiovascular events like stroke and myocardial infarction. The tablets can be administered with or without food, the dosage being tailored to individual response and medical condition. Consistent daily timing is recommended. Continuous use, as directed by your physician, is crucial; discontinuation may heighten the risk of stroke or heart attack. As this medication includes a diuretic, increased urination is expected; therefore, avoid dosing within four hours of bedtime. Regular intake, even during symptom-free periods, maximizes therapeutic efficacy. Hypertension often presents asymptomatically. Common side effects include headache, fatigue, dizziness, altered taste perception, flu-like symptoms, diarrhea, and sinus inflammation. Report persistent, worsening, or bothersome side effects to your doctor promptly. Maintain adequate hydration to mitigate potential side effects such as thirst, dry mouth, and muscle weakness. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, and pregnant or breastfeeding individuals should seek medical guidance. Inform your doctor about all concurrent medications, particularly those for cardiovascular or hypertensive conditions. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is necessary to optimize treatment efficacy.
Uses of Telmitos AM 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Telmitos AM 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 40mg/5mg/12.5mg Telmitos AM Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, however, consistent daily timing is recommended.
Common Side effects of Telmitos AM 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telmitos AM 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmitos AM 40mg/5mg/12.5mg tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency in timing is recommended.
How Telmitos AM 40mg/5mg/12.5mg Tablet works:
Telmisartan, Amlodipine, and Hydrochlorothiazide (40mg/5mg/12.5mg) combine in Telmitos AM tablets to effectively manage blood pressure. Telmisartan, an angiotensin receptor blocker (ARB), and Amlodipine, a calcium channel blocker (CCB), both act to dilate blood vessels, reducing blood pressure. The diuretic, Hydrochlorothiazide, facilitates the excretion of excess fluid and electrolytes via urine, contributing to vasodilation and improved circulation over time.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Telmitos AM 40mg/5mg/12.5mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Telmitos AM 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in rare, life-threatening circumstances where the potential benefits outweigh the known hazards. Always seek medical advice before use.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Telmitos AM 40mg/5mg/12.5mg Tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Telmitos AM 40mg/5mg/12.5mg Tablets. These potential side effects include dizziness, headaches, nausea, and fatigue, all of which can reduce concentration and driving aptitude.
KidneyCAUTION
Patients with severe kidney impairment should use Telmitos AM 40mg/5mg/12.5mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Telmitos AM 40mg/5mg/12.5mg tablets are unsuitable for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Telmitos AM 40mg/5mg/12.5mg Tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telmitos AM 40mg/5mg/12.5mg Tablet :
Should you forget a Telmitos AM 40mg/5mg/12.5mg Tablet dose, ingest it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmitos AM 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | HEART |
